Cognition in the PREDICT-PD Cohort
Objective: To identify whether there is evidence for cognitive dysfunction in participants identified as being at higher risk of Parkinson’s disease (PD) using the PREDICT-PD…Do Acetylcholinesterase Inhibitors (AChEI) delay institutionalisation in Parkinson’s and Lewy Body Disease?
Objective: We explored the use of Rivastigmine in Parkinson’s and Lewy body dementia through assessment of quantitative data obtained from a clinical database. We focussed…Action Verbal Fluency is Related to the Functional Integrity of the Cognitive Cortico-Striatal Loop in Parkinson’s Disease
Objective: The objective of this study is to investigate the relationship between action verbal fluency (the capacity to name as many action words as possible…Subjective cognitive decline reflects recent cognitive change in non-demented patients with Parkinson’s disease
Objective: We investigated whether subjective cognitive decline (SCD) can reflect recent cognitive change in patients with Parkinson’s disease (PD) who had shown non-demented cognitive performance…IGF-1 levels are associated with CSF pathology and executive dysfunction in de novo Parkinson’s disease patients
Objective: To investigate whether serum insulin-like growth factor-1 (IGF-1) is associated with clinical-neuropsychiatric, imaging and CSF markers of PD pathology in patients with early, drug-naïve…Prediction of cognitive progression in Parkinson’s disease using three cognitive screening measures
Objective: To assess the utility of commonly used cognitive screening tools in predicting the transition to mild cognitive impairment (MCI) and/or dementia (PDD) in Parkinson’s…Pro-saccades predict decline in attention over 18months in newly diagnosed Parkinson’s disease
Objective: This study investigated 1) pro-saccades in a newly diagnosed cohort of Parkinson’s disease (PD) compared to healthy older adult controls at baseline, and 2)…Intention Awareness in Parkinson’s Disease
Objective: To investigate the role of dopamine in intention awareness of voluntary actions in patients with Parkinson’s Disease (PD). Background: Underactivation of the SMA due…Event-related potentials and mild cognitive impairment in Parkinson’s disease.
Objective: To measure N170, P3a/P3b peak amplitudes and latencies in PD with (PD-MCI) and without (PD-NC) mild cognitive impairment and to correlate them with clinical-demographic, neuropsychological and…Motor resonance in Parkinson’s disease: Effects of observed actions on behaviour
Objective: To investigate whether people with Parkinson’s disease (PD) exhibit motor resonance from observed human actions. Background: Seeing another person move can influence one’s own…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.